| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |